患者来源外植体模型揭示肿瘤微环境对治疗反应的影响
本研究利用患者来源外植体(PDE)模型,将根治性前列腺切除术的新鲜前列腺癌组织进行体外培养,以评估个体化治疗反应。PDE维持了原生肿瘤微环境(TME)、组织形态、活力和内源性激素信号,肿瘤细胞表现出原位增殖能力。TME分析首次揭示了患者特异性促结缔组织增生基质指数,并可预测对AR靶向治疗的反应性。
要点
- PDE模型保留原生TME,可个体化评估前列腺癌治疗反应。
- 患者特异性促结缔组织增生基质指数可预测AR靶向治疗反应。
- PDE模型有望推动精准医学并识别新的基质标志物。
核心结论
- PDE模型可在原生TME中综合评估个体肿瘤,助力开发个体化治疗方案。
- 识别新型基质标志物可为晚期前列腺癌精准医学提供依据。
研究设计与样本
- 研究采用患者来源外植体(PDE)ex vivo培养方法,使用根治性前列腺切除术的新鲜前列腺癌组织。
- 通过基因组和化学扰动评估PDE中AR水平、Ki67染色和促结缔组织增生指数等参数。
主要发现
- PDE维持了原生TME完整性、肿瘤组织形态、活力和内源性激素信号。
- PDE中肿瘤细胞表现出原位增殖能力。
- PDE中原生TME分析首次揭示了患者特异性促结缔组织增生基质指数,并预测对AR靶向治疗的反应性。
临床怎么用
- PDE模型可用于预测前列腺癌患者对治疗的反应并识别晚期疾病的新靶点。
- 基于PDE的基质指数分析有望辅助精准医学实施,改善患者预后。
局限性
- 摘要未明确报告PDE模型的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Androgen deprivation therapy is a first-line treatment for disseminated prostate cancer (PCa). However, virtually all tumors become resistant and recur as castration-resistant PCa, which has no durable cure. One major hurdle in the development of more effective therapies is the lack of preclinical models that adequately recapitulate the heterogeneity of PCa, significantly hindering the ability to accurately predict therapeutic response. OBJECTIVE: To leverage the ex vivo culture method termed patient-derived explant (PDE) to examine the impact of PCa therapeutics on a patient-by-patient basis. DESIGN SETTING AND PARTICIPANTS: Fresh PCa tissue from patients who underwent radical prostatectomy was cultured as PDEs to examine therapeutic response. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The impact of genomic and chemical perturbations in PDEs was assessed using various parameters (eg, AR levels, Ki67 staining, and desmoplastic indices). RESULTS AND LIMITATIONS: PDE maintained the integrity of the native tumor microenvironment (TME), tumor tissue morphology, viability, and endogenous hormone signaling. Tumor cells in this model system exhibited de novo proliferative capacity. Examination of the native TME in the PDE revealed a first-in-field insight into patient-specific desmoplastic stromal indices and predicted responsiveness to AR-directed therapeutics. CONCLUSIONS: The PDE model allows for a comprehensive evaluation of individual tumors in their native TME to ultimately develop more effective therapeutic regimens tailored to individuals. Discernment of novel stromal markers may provide a basis for applying precision medicine in treating advanced PCa, which would have a transformative effect on patient outcomes. PATIENT SUMMARY: In this study, an innovative model system was used to more effectively mimic human disease. The patient-derived explant (PDE) system can be used to predict therapeutic response and identify novel targets in advanced disease. Thus, the PDE will be an asset for the development of novel metrics for the implementation of precision medicine in prostate cancer.The patient-derived explant (PDE) model allows for a comprehensive evaluation of individual human tumors in their native tumor microenvironment (TME). TME analysis revealed first-in-field insight into predicted tumor responsiveness to AR-directed therapeutics through evaluation of patient-specific desmoplastic stromal indices.
引用
- Shafi AA, Schiewer MJ, de Leeuw R, et al. Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response. Eur Urol Oncol. 2018. PMID: 30467556. doi:10.1016/j.euo.2018.04.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。